KERNX Health Tirzepatide Review: Cost, a Self-Contradicting Pricing Page & Honest Verdict (2026)

KERNX Health has a genuine self-contradiction on its own pricing page. The page states there are no separate consultation charges, then in the same breath lists consult fees of $25 to $60 depending on visit type — both statements present on the same page. Every fact here comes from the company's own published program.

A pricing page that contradicts itself

This review independently confirmed a genuine self-contradiction on KERNX Health's own pricing page: it claims no separate consultation charges, then in the same breath states a $25 fee for a message-based review, $35 for a standard live visit, or $60 for a complex live visit — the consult fee is charged whether or not a prescription is issued. Both statements sit on the same page. Budget for the consult fee despite the "no separate charges" claim.

What KERNX Health is

KERNX Health is a Washington DC telehealth platform, selling compounded semaglutide and tirzepatide on flat monthly plans. Its LegitScript certification was verified against the issued seal, not just the badge — a genuinely stronger verification than most competitors offer.

What KERNX Health costs

$199/month and $129/month figures both appear, with $249 and $299 also present. The $129 and $199 rates are time-limited founding rates; standard rates are $249 and $299.

Conflicting shipping claims

Worth flagging: KERNX Health's homepage claims a 48-hour shipping figure, while its own FAQ states 1-2 days to ship plus 2-3 days transit — a longer total than the headline claim suggests. Confirm current shipping timelines directly.

The brand-vs-compounded question

KERNX Health dispenses compounded tirzepatide, not the FDA-approved branded product. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

KERNX Health's real strengths: openly published plan pricing before intake, month-to-month with no long-term contract, billing starts only after provider approval, and a genuinely verified LegitScript seal. The trade-offs are real: a confirmed self-contradiction between "no consult charges" and an actual $25-$60 per-visit fee, the advertised founding rates are time-limited (standard rates run $249/$299), no compounding pharmacy is named, and conflicting shipping-time claims appear on the homepage versus the FAQ. As with any GLP-1 program, and especially one with a self-contradicting pricing page, get your total cost — including the consult fee — confirmed directly before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

KERNX Health's genuinely verified LegitScript seal is a real trust signal, but its pricing page directly contradicts itself on consultation fees — this review confirmed both conflicting statements on the same page. Budget for the $25-$60 consult charge, and confirm the founding-rate discount is still active before assuming $129/$199 applies to you. For a provider with genuinely consistent, self-reconciling pricing, compare it against CoreAge Rx or Harper Meds. For another provider with a real LegitScript-badge caveat this review flagged directly, see MediRX. See our best tirzepatide providers ranking for the full field.